The National Institutes of Health (NIH) has announced a new funding opportunity, designated as PAR-24-044, specifically targeting Small Business Concerns (SBCs). This grant falls under the auspices of the National Institute of Neurological Disorders and Stroke (NINDS) and is focused on supporting exploratory clinical trials in the field of neuroscience. The initiative is designed to foster advancements in the diagnosis, treatment, and understanding of neurological disorders, aligning with the NINDS’s mission and goals.
Eligibility for this grant is specifically directed towards small businesses, with a clear emphasis on encouraging innovative research and development in the neurosciences. The funding opportunity is open to applications proposing the evaluation of drugs, biologics, devices, diagnostics, surgical procedures, behavioral therapies, or rehabilitation therapies. Importantly, the program supports only STTR Phase II and Fast-Track applications, with STTR Phase I applications being accepted only as part of a Fast-track application. The closing date for applications is set for September 5, 2026, providing a substantial window for interested parties to develop and submit their proposals. This funding opportunity represents a significant step towards encouraging small businesses to engage in groundbreaking research that could lead to major advancements in the treatment and understanding of neurological disorders.
Opportunity ID: 351150
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-24-044 |
| Funding Opportunity Title: | NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | |
| Expected Number of Awards: | |
| CFDA Number(s): | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 27, 2023 |
| Last Updated Date: | Nov 27, 2023 |
| Original Closing Date for Applications: | Sep 05, 2026 |
| Current Closing Date for Applications: | Sep 05, 2026 |
| Archive Date: | Oct 11, 2026 |
| Estimated Total Program Funding: | |
| Award Ceiling: | $ |
| Award Floor: | $ |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | (Reissue of PAR-18-617) The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Technology Transfer (STTR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only STTR Phase II and Fast-Track applications are supported under this program. STTR Phase I applications are only accepted as part of a Fast-track application. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-24-044.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact: NIH Grants Information
grantsinfo@nih.gov |